Cameron Turtle - Chief Executive Officer, Director at Spyre Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Executive Officer, Director
Issuer Symbol
SYRE on Nasdaq
All Insider Reports
All Insider Reports

Cameron Turtle - trading volume in the past year for Spyre Therapeutics, Inc.

Holdings reported by Cameron Turtle for Spyre Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 657,540 $21,613,339 $32.87 02 Feb 2026 Direct
Stock Option (Right to Buy) 528,000 09 Jan 2026 Direct Common Stock

Transactions reported by Cameron Turtle for Spyre Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.